T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$1.37B |
| 2 |
Intel
INTC
|
+$1.28B |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$1B |
| 4 |
Nike
NKE
|
+$859M |
| 5 |
Uber
UBER
|
+$825M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.67B |
| 2 |
Amazon
AMZN
|
+$2.15B |
| 3 |
NVIDIA
NVDA
|
+$1.64B |
| 4 |
Humana
HUM
|
+$1.57B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.09% |
| 2 | Healthcare | 15.81% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Erasca
ERAS
$4.98B
| $43K | ﹤0.01% |
19,931
+2,250
| +13% | +$4.75K |
|
|
SUNW
2827
DELISTED
Sunworks, Inc.
SUNW
| $43K | ﹤0.01% |
182,700
+109,300
| +149% | +$37.2K |
|
2828
BRC Inc
BRCC
$131M
| $42K | ﹤0.01% |
+1,126
| New | +$38.8K |
|
2829
Purple Innovation
PRPL
$10.8M
| $41K | ﹤0.01% |
1,584
| – | – |
|
|
BMTX
2830
DELISTED
BM Technologies, Inc.
BMTX
| $41K | ﹤0.01% |
19,800
| – | – |
|
2831
Kaltura
KLTR
$201M
| $40K | ﹤0.01% |
20,395
+3,507
| +21% | +$6.19K |
|
2832
System1
SST
$24.6M
| $40K | ﹤0.01% |
1,760
+325
| +23% | +$4.81K |
|
2833
Dare Bioscience
DARE
$15.3M
| $39K | ﹤0.01% |
10,492
| – | – |
|
2834
Intellicheck
IDN
$48.4M
| $38K | ﹤0.01% |
19,500
| – | – |
|
2835
ThredUp
TDUP
$296M
| $38K | ﹤0.01% |
16,746
+1,040
| +7% | +$2.7K |
|
2836
Bakkt Inc
BKKT
$383M
| $37K | ﹤0.01% |
655
| – | – |
|
2837
CareCloud
CCLD
$87.1M
| $37K | ﹤0.01% |
23,700
| – | – |
|
2838
Compass Therapeutics
CMPX
$203M
| $37K | ﹤0.01% |
23,355
+2,892
| +14% | +$5K |
|
|
BLUE
2839
DELISTED
bluebird bio
BLUE
| $36K | ﹤0.01% |
1,280
+120
| +10% | +$7.32K |
|
2840
Nautilus Biotechnolgy
NAUT
$123M
| $36K | ﹤0.01% |
11,839
+1,389
| +13% | +$3.97K |
|
|
EMKR
2841
DELISTED
Emcore Corp
EMKR
| $36K | ﹤0.01% |
7,160
| – | – |
|
|
TSP
2842
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $35K | ﹤0.01% |
38,761
+3,195
| +9% | +$3.27K |
|
2843
Expensify
EXFY
$202M
| $33K | ﹤0.01% |
13,003
+791
| +6% | +$2.05K |
|
2844
Dakota Gold
DC
$887M
| $32K | ﹤0.01% |
12,125
| – | – |
|
2845
Goldgroup Mining
GORO
$475M
| $32K | ﹤0.01% |
21,175
| – | – |
|
2846
MediciNova
MNOV
$127M
| $32K | ﹤0.01% |
20,700
| – | – |
|
|
KLRS
2847
Kalaris Therapeutics
KLRS
$69.5M
| $30K | ﹤0.01% |
1,873
| – | – |
|
|
MOND
2848
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
| $30K | ﹤0.01% |
+10,692
| New | +$38.1K |
|
2849
Atara Biotherapeutics
ATRA
$88.4M
| $29K | ﹤0.01% |
2,200
| – | – |
|
2850
DHI Group
DHX
$205M
| $29K | ﹤0.01% |
+11,182
| New | +$28.8K |
|
Similar funds
T. Rowe Price Associates's Q4 2023 Portfolio in Review
As of Q4 2023, T. Rowe Price Associates held 2,974 positions worth $744B, up 9.1% from $682B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates's Q4 2023 filing shows 92 new, 1,834 increased, 805 reduced and 67 closed positions. Its largest new stake was Canadian Natural Resources: 6,473,658 shares worth $212M. The largest sale was Microsoft, an estimated $2.67B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2023 buy was Canadian Natural Resources: 6,473,658 shares worth $212M.
- T. Rowe Price Associates added most to Dollar General in Q4 2023, an estimated $1.37B increase.
- T. Rowe Price Associates's biggest Q4 2023 reduction was Microsoft, cutting an estimated $2.67B.
- T. Rowe Price Associates fully exited Activision Blizzard in Q4 2023, selling an estimated $293M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $744B portfolio in Q4 2023.
- T. Rowe Price Associates opened 92 new positions and closed 67 in Q4 2023.
- T. Rowe Price Associates's portfolio value rose 9.1% quarter-over-quarter to $744B.
Based on T. Rowe Price Associates's 13F filing for Q4 2023, filed 14 Feb 2024.